-
13202-10A naturally-occurring isoflavone with anti-oxidant, anti-carcinogenic, and anti-atherosclerotic activities directly inhibits mitochondrial aldehyde dehydrogenase 2 (IC<sub>50</sub> = 80 nM) and is an effective anti-dipsotropic isoflavone.
-
13202-100A naturally-occurring isoflavone with anti-oxidant, anti-carcinogenic, and anti-atherosclerotic activities directly inhibits mitochondrial aldehyde dehydrogenase 2 (IC<sub>50</sub> = 80 nM) and is an effective anti-dipsotropic isoflavone.
-
13202-5A naturally-occurring isoflavone with anti-oxidant, anti-carcinogenic, and anti-atherosclerotic activities directly inhibits mitochondrial aldehyde dehydrogenase 2 (IC<sub>50</sub> = 80 nM) and is an effective anti-dipsotropic isoflavone.
-
13202-50A naturally-occurring isoflavone with anti-oxidant, anti-carcinogenic, and anti-atherosclerotic activities directly inhibits mitochondrial aldehyde dehydrogenase 2 (IC<sub>50</sub> = 80 nM) and is an effective anti-dipsotropic isoflavone.
-
89450-1An inhibitor of CETP inhibits plasma CETP with an IC<sub>50</sub> value of 9 µM in rabbits given an atherogenic diet, increases HDL, decreases VLDL, and attenuates induced atherosclerosis in humans, inhibits CETP activity and increases HDL
-
89450-10An inhibitor of CETP inhibits plasma CETP with an IC<sub>50</sub> value of 9 µM in rabbits given an atherogenic diet, increases HDL, decreases VLDL, and attenuates induced atherosclerosis in humans, inhibits CETP activity and increases HDL
-
89450-5An inhibitor of CETP inhibits plasma CETP with an IC<sub>50</sub> value of 9 µM in rabbits given an atherogenic diet, increases HDL, decreases VLDL, and attenuates induced atherosclerosis in humans, inhibits CETP activity and increases HDL
-
89450-50An inhibitor of CETP inhibits plasma CETP with an IC<sub>50</sub> value of 9 µM in rabbits given an atherogenic diet, increases HDL, decreases VLDL, and attenuates induced atherosclerosis in humans, inhibits CETP activity and increases HDL
-
19762-1A streptogramin antibiotic that is usually combined with another streptogramin antibiotic, quinupristin, to synergistically kill Gram-positive bacteria.
-
19762-5A streptogramin antibiotic that is usually combined with another streptogramin antibiotic, quinupristin, to synergistically kill Gram-positive bacteria.
-
12033-10A selective inhibitor of the human 2-oxoglutarate (JmjC) histone demethylases KDM2A, PHF8, and KDM7A (IC50s = 1.5, 0.55, and 2.1 &muM, respectively).
-
12033-25A selective inhibitor of the human 2-oxoglutarate (JmjC) histone demethylases KDM2A, PHF8, and KDM7A (IC50s = 1.5, 0.55, and 2.1 &muM, respectively).